Some of the material in is restricted to members of the community. By logging in, you may be able to gain additional access to certain collections or items. If you have questions about access or logging in, please use the form on the Contact Page.
Lacasse, J. R., & Leo, J. (2007). Truthiness in Direct-to-Consumer Advertising. Retrieved from http://purl.flvc.org/fsu/fd/FSU_migr_csw_faculty_publications-0049
Dr. Frosch and colleagues' research provides important counterevidence to the pharmaceutical industry's claim that consumer advertising has educational value [1]. We would like to suggest an additional point which will strengthen their conclusions. Zoloft advertisements (one of the data points captured in their analysis) claim that various mental disorders are caused by a lack of serotonin and that this putative imbalance is remedied by Zoloft. However, these claims are contradicted by a large body of empirical evidence and we have argued that they are misleading and incongruent with FDA labeling (2). Providing metaphorical or theoretical explanations as factual will likely increase the sales of Zoloft, but it will not provide consumers with educational content. Thus, future studies should address not only the type of appeal made to consumers, but also the veracity of the information provided. References 1. Bonaccorso SN, Sturchio JL. For and against: Direct to consumer advertising is medicalising normal human experience: Against. BMJ. 2002 Apr 13;324(7342):910-1.Click here to read 2. Lacasse JR, Leo J. Serotonin and Depression: A Disconnect between the Advertisements and the Scientific Literature. PLoS Medicine Vol. 2, No. 12, e392 doi:10.1371/journal.pmed.0020392.
Keywords
sertraline, direct-to-consumer advertising, Food and Drug Administration, accuracy, progaganda
Identifier
FSU_migr_csw_faculty_publications-0049
Language
English
Lacasse, J. R., & Leo, J. (2007). Truthiness in Direct-to-Consumer Advertising. Retrieved from http://purl.flvc.org/fsu/fd/FSU_migr_csw_faculty_publications-0049